Skip to site content
U.S. Department of Health and Human Services

California Area Office logoCalifornia Area Office

Next Steps: Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) / Metabolic Dysfunction-Associated Steatohepatitis (MASH) – in Type 2 Diabetes

Next Steps: Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) / Metabolic Dysfunction-Associated Steatohepatitis (MASH) – in Type 2 Diabetes

August 20, 2026

Register online:

https://ihs-gov.zoomgov.com/meeting/register/IvFDqScCSBK3b5kA5Th-ww

Description:

This session will review management strategies for MASLD/MASH in patients with type 2 diabetes, with a focus on lifestyle interventions, glycemic management, statin therapy, liver-directed treatment options, and non-invasive monitoring to improve patient outcomes.

Presenter:

Carol Greenlee, MD, MACP, Physician (Endocrinology)

Downloads:

Continuing Education (CE) Flyer (PDF)